ROBLE, BELKO & COMPANY, INC – Vertex Pharmaceuticals Incorporated Transaction History
ROBLE, BELKO & COMPANY, INC portfolio value:
$99,000
portfolio value
ROBLE, BELKO & COMPANY, INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 3K | $289.54 | 342 | |
| Q2 2022 | share | 0.00% | 0 shares | 7K | $281.79 | 342 | |
| Q1 2022 | share | Decrease | -3.39% | -12 shares | 11K | $260.97 | 342 |
| Q4 2021 | share | 0.00% | 0 shares | 14K | $222.45 | 354 | |
| Q3 2021 | share | 0.00% | 0 shares | -7K | $181.39 | 354 | |
| Q2 2021 | share | 0.00% | 0 shares | -5K | $201.63 | 354 | |
| Q1 2021 | share | 0.00% | 0 shares | -8K | $214.89 | 354 | |
| Q4 2020 | share | 0.00% | 0 shares | -12K | $236.34 | 354 | |
| Q3 2020 | share | Increase | +3.51% | 12 shares | -3K | $272.12 | 354 |
| Q2 2020 | share | 0.00% | 0 shares | 18K | $290.31 | 342 | |
| Q1 2020 | share | 0.00% | 0 shares | 6K | $237.95 | 342 | |
| Q4 2019 | share | 0.00% | 0 shares | 17K | $218.95 | 342 | |
| Q3 2019 | share | 0.00% | 0 shares | -5K | $169.42 | 342 | |
| Q2 2019 | share | 0.00% | 0 shares | 0 | $183.38 | 342 | |
| Q1 2019 | share | 0.00% | 0 shares | 6K | $183.95 | 342 | |
| Q4 2018 | share | 0.00% | 0 shares | -9K | $165.71 | 342 | |
| Q3 2018 | share | 0.00% | 0 shares | 8K | $192.74 | 342 | |
| Q2 2018 | share | 0.00% | 0 shares | 2K | $169.96 | 342 | |
| Q1 2018 | share | Increase | +15.93% | 47 shares | 12K | $162.98 | 342 |
| Q4 2017 | share | Increase | 0.00% | 295 shares | 44K | $149.86 | 295 |
| Q2 2017 | share | Decrease | -100.00% | -23 shares | -3K | $128.87 | 0 |
| Q1 2017 | share | 0.00% | 0 shares | 1K | $109.35 | 23 | |
| Q4 2016 | share | Increase | 0.00% | 23 shares | 2K | $73.67 | 23 |